High Performance Beverages (TBEV) 10-Q 30 Apr 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jan. 31, 2014	Apr. 15, 2014
Document And Entity Information	'	'
Entity Registrant Name	'HIGH PERFORMANCE BEVERAGES CO.	'
Entity Central Index Key	'0001504222	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--07-31	'
Document Type	'10-Q	'
Document Period End Date	31-Jan-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	134,582,603

Balance_Sheets

Balance Sheets (USD $)	Jan. 31, 2014	Jul. 31, 2013
Current Assets	'	'
Cash	$12,403	$3,920
Inventory	31,149	31,034
Deferred loan costs	'	174,857
Total Current Assets	43,552	209,811
TOTAL ASSETS	43,552	209,811
Current Liabilities	'	'
Accrued expenses	143,052	76,979
Convertible notes payable, net of discount of $88,852 and 0, respectively	366,948	270,000
Derivative liability	899,350	242,430
Total Current Liabilities	1,409,350	589,409
Total Liabilities	1,409,350	589,409
Commitments and contingencies (Note 6)	'	'
Stockholders' (Deficit)	'	'
Preferred stock: $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding	'	'
Common stock: $0.001 par value; 500,000,000 shares authorized; 134,582,603 and 103,970,000 shares issued and outstanding at January 31, 2014 and July 31, 2013, respectively	134,583	103,970
Stock subscriptions payable	260,239	220,839
Additional paid-in capital	2,695,611	1,662,132
Retained earnings from discontinued operations	6,944	6,944
Accumulated deficit	-4,463,175	-2,373,483
Total Stockholders' (Deficit)	-1,365,798	-379,598
Total Liabilities and Stockholders' Deficit	$43,552	$209,811

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Jan. 31, 2014	Jul. 31, 2013
Stockholders' equity:	'	'
Net of discount on convertible notes payable	$88,852	$0
Preferred stock, par value	$0.00	$0.00
Preferred stock, share authorized	1,000,000	1,000,000
Preferred stock, shares issued	'	'
Preferred stock, shares outstanding	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	134,582,603	103,970,000
Common stock, shares outstanding	134,582,603	103,970,000

Statements_of_Operations

Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Income Statement [Abstract]	'	'	'	'
REVENUES	$1,108	'	$1,481	'
COST OF GOOD SOLD	2,971	'	4,363	'
GROSS (LOSS)	-1,863	'	-2,882	'
OPERATING EXPENSES	'	'	'	'
General and administrative	19,151	122,293	96,761	175,673
Marketing	7,314	139,998	14,392	183,129
Product development	'	15,275	'	37,019
Compensation	52,932	12,500	1,039,992	314,500
TOTAL OPERATING EXPENSES	79,397	290,066	1,151,145	710,321
OTHER (INCOME) EXPENSE	'	'	'	'
Interest expense	53,062	8,389	262,330	8,389
Change in fair value of derivative liability	-241,147	'	656,920	'
Total Other (Income ) Expenses	-188,085	8,389	919,250	8,389
NET LOSS	$106,825	($298,455)	($2,073,277)	($718,710)
NET LOSS PER SHARE: BASIC AND DILUTED	$0	$0	($0.02)	($0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	116,726,284	96,466,703	108,352,514	95,292,077

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	6 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net (loss)	($2,073,277)	($718,710)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Share-based compensation	966,292	470,939
Amortization of deferred financing costs	174,857	107,779
Amortization of debt discount	11,148	'
Change in derivative liability	656,920	'
Changes in assets and liabilities:	'	'
Inventory	-115	-64,238
Accrued expenses	49,658	17,698
Cash Flows Provided by (Used in) Operating Activities	-214,517	-208,832
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Cash Flows Provided by (Used) in Investing Activities	'	'
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from convertible notes payable	223,000	100,000
Sales of common stock	'	111,361
Cash Flows Provided by Financing Activities	223,000	211,361
NET INCREASE IN CASH	8,483	2,529
Cash, beginning of period	3,920	'
Cash, end of period	12,403	2,529
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Cash paid for interest	'	'
Cash paid for income taxes	'	'
Conversion of convertible notes payable	16,000	'
Shares issued for loan origination costs	$325,000	'

Basis_of_Presentation_and_Acco

Basis of Presentation and Accounting Policies	6 Months Ended
	Jan. 31, 2014
Basis of Presentation and Accounting Policies [Abstract]	'
BASIS OF PRESENTATION AND ACCOUNTING POLICIES	'
	NOTE 1 - BASIS OF PRESENTATION AND ACCOUNTING POLICIES
	Interim financial statements
	The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission set forth in Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Unaudited interim results are not necessarily indicative of the results for the full fiscal year.  These financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended July 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K.
	Share-Based Compensation
	The Company issues stock-based compensation awards to contractors, vendors and for marketing purposes. This compensation is generally in the form of restricted shares of common stock.
	The Company measures and recognizes compensation expense for all stock-based awards based on the awards' fair value which is generally the quoted market value of common shares on the date that the contract mandating the award issuance is executed. The Company recognizes the expense on a straight-line basis over the service period of the related contract. However, if shares of common stock are issued as of the inception of a contract period and the Company does not have the right to recover any of the shares for nonperformance, the entire expense is recognized at the inception date of the contract.
	Basic and Diluted Loss Per Common Share
	Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic and diluted net income per common share has been calculated by dividing the net income for the period by the basic and diluted weighted average number of common shares outstanding assuming that the Company incorporated as of the beginning of the first period presented. There were no dilutive shares outstanding at January 31, 2014 or 2012.  Issuable common stock is not included in the calculation of basic or diluted weighted average number of common shares outstanding because including these shares would be antidilutive.
	Discontinued Operations
	In accordance with ASC 205-20, Presentation of Financial Statements-Discontinued Operations (“ASC 205-20”), the Company reported the results of its commercial cleaning services as a discontinued operation. The results of operations of business dispositions are   segregated from continuing operations and reflected as discontinued operations in current and prior periods. The application of the principle is discussed in Note 5, Discontinued Operations.
	Recently Issued Accounting Standards
	There were no new accounting pronouncements that had a significant impact on the Company’s operating results or financial position.

Going_Concern

Going Concern	6 Months Ended
	Jan. 31, 2014
Going Concern [Abstract]	'
GOING CONCERN	'
	NOTE 2 - GOING CONCERN
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As reflected in the accompanying financial statements, the Company had negative working capital and a net stockholders’ deficit at January 31, 2014 and had no committed source of debt or equity financing.
	While the Company is emphasizing a new product line involving the manufacture and sale of sports performance or energy drinks along with any other non-alcoholic beverage under the trade name, Throwdown, there are uncertainties as to whether the Company will obtain sufficient financing to introduce and distribute the planned product or, if distributed, there will be sufficient market demand for the products.
	The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Convetible_Notes_Payable

Convetible Notes Payable	6 Months Ended
	Jan. 31, 2014
Convertible Notes Payable [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	NOTE 3 - CONVERTIBLE NOTES PAYABLE
	Convertible notes payable consists of the following:
		January 31,			July 31,
	Description	2014			2013
	On November 15, 2012, the Company entered into a Senior Secured Promissory Note (the “Note”) with an unaffiliated party (the “Third Party”) under which the Company received a one-year loan with a principal balance of $100,000. The loan bears interest at 20% per annum with interest payments due quarterly. In addition, the Company issued 2,500,000 shares of restricted common stock to the lender and Mr. Holley and McBride pledged their 56,250,000 shares of the Company’s common stock as collateral and transferred 1,000,000 shares of free trading shares to the lender. If the Company goes into default of the provisions of the loan, it becomes convertible into the Company’s common stock at a price of $0.001 per share (100 million shares). If an event of default occurs, the lender will have the ability of becoming the controlling shareholder of the Company. The Company recorded deferred financing costs of $560,000 in connection with these transfers.  The deferred financing costs is being amortized to interest expense over the term of the loan or twelve months. The company reflected amortization on the deferred financing costs in the amount of $148,111 for the three months ended January 31, 2014, which is reflected in the statement of operations.  On June 20, 2013, the Company and the Third party entered into an Amended and Restated Senior Secured Convertible Promissory Note (the “Amended Note”) which amended certain terms of the Note. Pursuant to the Amended Note, the Company’s repayment of the principal balance of the Amended Note is secured by all the assets of the Company. In addition, the provisions of the Note whereby Mssrs. Holley and McBride pledged 56,250,000 of their shares of common stock of the Company were removed.	$	100,000		$	100,000
	On February 27, 2013, the Company entered into a $335,000 convertible loan agreement. The agreement provides for a $35,000 original issue discount. The lender, at its discretion, may provide funds up to $300,000 to the Company. It provided $60,000 at the closing of the agreement on April 30, 2013. All loans under the agreement are payable in full one year after the funds are issued together with a prorated portion of the original issue discount. All amounts outstanding under the agreement become convertible, at the lender’s discretion, into shares of the Company’s common stock starting 180 days from the execution date of the agreement. The conversion rate per share is the lower of (i) $0.044 or (ii) 60% of the lowest trade price during the 25 trading days prior to a conversion notice. The lender has agreed that it will not execute any short trades and, at no time, will hold more than 4.9% of the Company’s outstanding common stock.		92,800			115,000
	If the Company repays all amounts outstanding under the agreement within 90 days of the execution date, there will be no interest amounts due. If it does not pay all amounts due within 90 days of the execution date, it cannot make any other prepayments of the amounts outstanding without the consent of the lender. In addition, there will be a one-time interest charge of 12% of the amounts outstanding. The Company must also register all shares that are issuable under the agreement in any Registration Statement that it files with the SEC for any purpose.
	On April 30, 2013, the Company sold an 18% Senior Convertible Debenture in the principal amount of $60,000 (the “Debenture”). The Debenture matures on April 30, 2014 and has an interest rate of 18% per annum payable monthly and on each conversion date. The conversion price of the Debenture is 65% of the average of the lowest three closing bid prices of the Common Stock for the twenty trading days immediately prior to the conversion date.		40,000			55,000
	Upon an Event of Default (as defined in the Debenture), the outstanding principal amount of the Debenture plus accrued but unpaid interest, liquidated damages and other amounts owing on the Debenture through the date of the acceleration shall become at the Debenture holder’s election immediately due and payable in cash at the Mandatory Default Amount (as defined in the Debenture). Commencing five days after the occurrence of an Event of Default that results in the eventual acceleration of the Debenture, the interest rate on the Debenture shall accrue at an interest rate equal to the lesser of 22% per annum or the maximum rate permitted under applicable law.
	In connection with the sale of the Debenture, on April 30, 2013 (the “Initial Exercise Date”) the Company issued the purchaser of the Debenture a warrant to purchase 3,726,708 shares of the Company’s common stock at an exercise price of $.03 per share (subject to adjustment as provided in the debenture). The Warrant is exercisable on a cashless basis (as provided in the Warrant) and as a result there is no assurance that any part of the Warrant will be exercised for cash. The warrant terminates three years from the Initial Exercise Date and on such date the Warrant shall be automatically exercised via cashless exercise. The fair market value of the warrant was $50,777 on the date of issuance.
	On October 10, 2013, Dethrone Royalty Holdings, Inc. (the “Company”), entered into a securities purchase agreement (the “SPA”) with an investor (“Investor”), pursuant to which the Investor purchased a master promissory note (the “Master Note”) with a principal balance of $48,000 for a purchase price of $40,000 at an original issuance discount of $4,000.  The Company also agreed to pay $4,000 worth of legal, accounting and due diligence costs to the Investor.		48,000			-
	Pursuant to the Master Note, the Investor has the right, solely in the Investor’s discretion, to subsequently purchase up to eight (8) additional promissory notes (each, an “Additional Note”, the Master Note and each Additional Note collectively, the “Notes”), at any time from the date of issuance of the Master Note until October 10, 2014.  Each Additional Note shall have a principal balance of $22,000 and shall have a purchase price of $20,000, at an original issue discount of $2,000.
	Pursuant to the Master Note, if the Company repays the entire balance of each Note prior to the Prepayment Opportunity Date (as defined in the Master Note), the Company shall pay an interest rate equal to 0% per annum.  If the Company does not repay the entire balance of each Note prior to the Prepayment Opportunity Date (as defined in the Master Note) each Note shall have a one-time interest charge equal to 12% , applied to the outstanding balance of each note.
	Each Note is convertible, at any time after the date six months from the Purchase Price Date (as defined in the Master Note), into shares of the Company’s common stock at an exercise price equal to (i) the outstanding balance divided by (ii) 60% of the lowest intra-day trade price in the twenty-five (25) trading days immediately preceding the conversion, subject to certain adjustment as further described in the Master Note (the “Conversion Price”).
	In connection with the SPA and the issuance of the Master Note, the Company issued to the Investor, warrants to purchase shares of the Company’s common stock (the “Warrant”) at an exercise price equal to the Conversion Price.  The Warrant has a term of five years.  The warrant provides for both cash and cashless exercise. The fair value of the warrant on the date of issuance was $295,273.
	8% Convertible Note, dated August 26, 2013, in the principal amount of $42,500 (the “Note”) pursuant to a Securities Purchase Agreement. The Note matures on May 21, 2014 and has an interest rate of 8% per annum until the Note becomes due. Any amount of principal or interest on the Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof.		42,500			-
	The Note may be converted into common stock of the Company at any time beginning on the 180 th day of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.
	If the Company fails to pay the principal hereof or interest thereon when due at the maturity date, the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the Default Sum (as defined in the Note). If the Company fails to issue common stock of the Company upon exercise of the Note, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum multiplied by two. Upon any other Event of Default (as defined in the Note), the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the greater of (i) 150% times the Default Sum or (ii) the “parity value” (as defined in the Note) of the Default Sum to be prepaid.
	On October 1, 2013, the Company, sold an 8% Convertible Note in the principal amount of $32,500 (the “Note”) pursuant to a Securities Purchase Agreement. The Note matures on June 19, 2014 and has an interest rate of 8% per annum until the Note becomes due. Any amount of principal or interest on the Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof.		32,500			-
	The Note may be converted into common stock of the Company at any time beginning on the 180 th day of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.
	If the Company fails to pay the principal hereof or interest thereon when due at the maturity date, the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the Default Sum (as defined in the Note). If the Company fails to issue common stock of the Company upon exercise of the Note, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum multiplied by two. Upon any other Event of Default (as defined in the Note), the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the greater of (i) 150% times the Default Sum or (ii) the “parity value” (as defined in the Note) of the Default Sum to be prepaid.
	On January 8, 2014, the Company sold a note with a principal balance of $75,000 for a purchase price of $50,000 at an original issuance discount of $25,000.  (the “January 2014 Note”).  The January 2014 Note matures on July 8, 2014.		75,000			-
	Original issued discount		(25,000	)		-
	Beneficial conversion feature		(75,000	)		-
	Less: Amortization of discounts		11,148			-
	Total convertible notes payable	$	366,948		$	270,000

Derivative_Liability

Derivative Liability	6 Months Ended
	Jan. 31, 2014
Derivative Liability [Abstract]	'
DERIVATIVE LIABILITY	'
	NOTE 4 - DERIVATIVE LIABILITY
	The convertible notes payable each contain a variable conversion feature (the Variable Conversion Feature) that gives rise to a derivative liability. We have measured this derivative at fair value and recognized the derivative value as a current liability and recorded the derivative value on our consolidated balance sheet. The derivative is valued primarily using models based on unobservable inputs that are supported by little to no market activity. These inputs represent management’s best estimate of what market participants would use in pricing the liability at the measurement date and thus are classified as Level 3. Changes in the fair values of the derivative are recognized in earnings in the current period. During the year ended July 31, 2013, the Company recorded a derivative liability of $235,165 related to the variable conversion feature of several convertible notes payable and recognized a change in the derivative liability of $7,265. At July 31, 2013, derivative liability was $242,430. Convertible notes payable issued during the six months ended January 31, 2014 and changes in volatility and interest rates resulted in an increase in the derivative liability of $656,920. The increase (decrease) in derivative liability during the three and six months ended January 31, 2014 was ($241,147) and $656,920, respectively, resulting in a balance of $899,350 as of January 31, 2014.

Equity

Equity	6 Months Ended
	Jan. 31, 2014
Equity [Abstract]	'
EQUITY	'
	NOTE 5 - EQUITY
	In August, 2013, the Company converted $10,200 in notes payable in exchange for 2,000,000 shares of its common stock in accordance with the note agreement.
	In October 2013, the Company converted $5,000 in notes payable in exchange for 5,000,000 the Company’s common stock in accordance with the note agreement.
	In October 2013, the Company issued 5,437,603 shares of its common stock in connection with the license agreement with Throwdown Industries Holdings, LLC. The fair market value of the shares on the date of issuance was $924,393, which was charged to expense as share based compensation during the six months ended January 31, 2014.
	In November 2013, the Company issued 75,000 shares to a consultant for services performed. The common stock had a fair market value of $1,500 on the date of issuance.
	In January 2014, the Company issued 2,100,000 shares to consultants for services performed.  The common stock had a fair market value of $26,000 on the dates of issuance.
	In January 2014, two note holders converted $22,000 in principal into 16,000,000 shares of common stock.
	In January 2014, the Company recognized $6,000 in expense related to celebrity endorsement contracts and increased the number of shares issuable in the Stock Subscriptions account by 300,000 shares.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Jan. 31, 2014
Commitments and Contingencies [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 6 - COMMITMENTS AND CONTINGENCIES
	In April 2012, the Company entered into an exclusive license agreement with Dethrone Royalty, Inc. giving the Company the right to use the Dethrone Trademark worldwide in connection with the manufacture and sale of sports performance or energy drinks along with any other non-alcoholic beverage under the Trade Name, Dethrone Beverages.
	The License Agreement with Dethrone Royalty, Inc. is for five years and requires payments as follows:
	Year	Royalty
	1	12% of Gross Profit
	2	$50,000 plus 8% of Gross Profit
	3	$100,000 or 6% of Gross profit, whichever is higher
	4	$150,000 or 6% of Gross profit, whichever is higher
	5	$200,000 or 6% of Gross profit, whichever is higher
	The License Agreement with Dethrone Royalty, Inc. specifies minimum levels of sales which, if not attained by the Company, gives Dethrone Royalty, Inc. the right to terminate the License Agreement. These minimums are as follows:
	Year	Minimum Sales
	1	$	-0-
	2	$	3,000,000
	3	$	6,000,000
	4	$	9,000,000
	5	$	12,000,000
	The License Agreement with Dethrone Royalty, Inc. also requires the Company to maintain various liability insurance coverage.
	In October 2013, the License Agreement with Dethrone Royalty, Inc, was terminated.
	On October 10, 2013, Dethrone Royalty Holdings, Inc. (the “Company”), entered into a license agreement (“License Agreement”) with Throwdown Industries Holdings, LLC, a Delaware limited liability company (“Licensor”), pursuant to which the Licensor granted an exclusive, non-sublicenseable and non-assignable right to the Company to use its trademarks and other intellectual properties (“Trademarks”) solely in connection with the development, manufacture, distribution, marketing and sale of sports performance drinks within the United States and Canada (the “License”) as well as a one-time right of first refusal to license other types of beverages. The Company’s rights under the License Agreement are contingent upon Licensor’s prior written approval of any sports performance drinks developed or proposed by the Company to contain any of the Trademarks (“Licensed Products”).
	In consideration for the License, the Company shall pay ten percent (10%) of the net revenue generated by all sales and other transfers of the Licensed Products during the term of the License Agreement. Notwithstanding the foregoing, the Company shall pay the minimum royalties as set forth below:
	0
		Time Period:		Minimum		Minimum
				Net		Quarterly
				Revenue		Payments
	(a)	Effective Date through 12/31/13				N/A
	(b)	01/01/14 through 12/31/14			1,000,000.00		37,500.00
	(c)	01/01/15 through 12/31/15			1,600,000.00		50,000.00
	(d)	01/01/16 through 12/31/16			2,500,000.00		75,000.00
	* 2015 minimum Net Revenue shall be the greater of 120% of the actual 2014 Net Revenue or $1,600,000.00.
	*** 2016 Minimum Net Revenue shall be the greater of 110% of the actual 2015 Net Revenue or $2,500,000.00. During any Extension Term and beyond 2016, the annual Minimum Net Revenue shall be at least 105% greater than the previous year.
	In addition to the cash payment, the Company will also issue 5,437,603 shares of its common stock to the Licensor. During each quarter of the term of the Agreement, the Licensor shall have the option to convert a portion or all of the greater of the minimum quarterly payments or the actual earned royalties into shares of stock of the Company at an exercise price equal to the lesser of $0.03 per share or the VWAP for the ten (10) trading days prior to the end of the respective quarter during the term.
	During the term of the License Agreement, the Licensor will not grant any license that will enable any third party to directly compete with the Company by selling other sports performance drinks within the United States and Canada. The License Agreement has an initial term of three (3) years and is automatically extended for one (1) additional three (3) year period unless either party elects not to extend the term.
	In the event the Licensor creates an independent and formal relationship with one of the Company’s athlete endorsers, the Licensor agrees to pay the Company twenty five percent (25%) of any compensation paid to the athlete endorser for athlete endorser participation.
	Either party may terminate the License Agreement upon thirty (30) days written notice if the other party is in material breach of the License Agreement and fails to cure or take reasonable steps to cure the breach within the given time period in accordance with the License Agreement. In addition, the Licensor has the right to terminate the License Agreement immediately upon occurrence of certain events pursuant to the License Agreement.
	On October 14, 2013, the licensor in this licensing agreement sent a notice of termination of this license agreement wherein it purposed to terminate this license agreement and demanded licensing fees of $475,000. The Company has asserted that the licensor has repudiated the license agreement and demanded damages of $850,000. This issue has not progressed passed this point and the Company is currently awaiting service of a complaint.
	Additionally, the Company is involved in a dispute with Overtime Marketing, SE, LLC and Overtime Marketing, LLC (“Potential Plaintiffs”) with which it had signed an agreement for marketing services. Potential plaintiffs have sent Company a demand letter seeking payment in the amount of $4,814,500 arising from an alleged breach of a term sheet that provided for the Company to compensate plaintiffs with up to 5,000,000 shares of its restricted common stock in exchange for certain marketing services. Settlement negotiations with potential plaintiffs are in process and Company legal counsel is unable at this time to estimate any potential liability of the Company resulting from this dispute. The Company is currently awaiting service of a complaint. No liability has been accrued as a result of this dispute.

Subsequent_Events

Subsequent Events	6 Months Ended
	Jan. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 7 - SUBSEQUENT EVENTS
	In November 2013, the Company issued 75,000 shares to a consultant for services performed.
	On January 22, 2014, High Performance Beverages Company, a Nevada corporation (the “Company”), sold an Original Issue Discount Convertible Promissory Note in the principal amount of $75,000, dated January 8, 2014 (the “Note”) for cash consideration of $50,000. The Note matures on July 8, 2014 (“Maturity Date”) and all overdue principal will entail a late fee at the rate of 22% per annum. The Company may prepay the Note for $100,000 at any time prior to the Maturity Date.
	The Note may be converted into common stock of the Company at any time after the Maturity Date at a fixed price of $0.0001 per share. However, if the stock price of the Company loses the bid at any time before the Maturity Date, the conversion price shall be $0.00001 per share. The Note shall not be converted to the extent that such conversion would result in beneficial ownership by the holder and its affiliates to own more than 4.99% of the issued and outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company.
	On February 14, 2014, High Performance Beverages Company, a Nevada corporation (the “Company”), sold an Original Issue Discount Convertible Promissory Note in the principal amount of $75,000, dated February 11, 2014 (the “Note”) for cash consideration of $50,000. The Note matures on August 11, 2014 (“Maturity Date”) and all overdue principal will entail a late fee at the rate of 22% per annum. The Company may prepay the Note for $75,000 at any time prior to May 11, 2014.
	The Note may be converted into common stock of the Company at any time after the Maturity Date at a fixed price of $0.0001 per share. However, if the stock price of the Company loses the bid, loses DTC eligibility, or gets “chilled for deposit” at any time before the Maturity Date, the conversion price shall be $0.00001 per share. The Note shall not be converted to the extent that such conversion would result in beneficial ownership by the holder and its affiliates to own more than 4.99% of the issued and outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company
	On March 6, 2014, High Performance Beverages Company, a Nevada corporation (the “Company”), sold a 10% Convertible Redeemable Note in the principal amount of $22,000 (the “Note”) pursuant to a Securities Purchase Agreement.   The Note matures on February 28, 2015 and has an interest rate of 10% per annum.
	The Note may be converted into common stock of the Company at any time beginning on the 180th day of the date of the Note at a price equal to 50% of the lowest closing bid price   of the common stock as reported on OTCQB, for the fifteen   prior   trading days. In the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 40% instead of 50% while that “Chill” is in effect.
	As previously reported by High Performance Beverages Company (the “Company”) on Form 8-K filed by the Company with the Securities and Exchange Commission, on  August 29, 2013, the Company on August 26, 2013, sold an 8% Convertible Note in the principal Amount of $42,500 (the “August 2013 Note”). As previously reported by the Company on Form 8-K filed by the Company with the Securities and Exchange Commission on October 4, 2013, the Company, on October 1, 2013, sold an 8% Convertible Note in the Principal amount of $32,500 (the “October Note” and together with the August 2013 Note, the “Notes”).  On March 24, 2014, the Company received correspondence stating that the Notes provide that the Company shall be in default if it fails to comply with the reporting requirements of the  Exchange Act of 1934, as amended and that based upon the foregoing the Company was now in default under the Notes.  As a result of the asserted default, demand was made for immediate payment as provided in the Notes in the amount of $113,625 (representing 150% of the remaining outstanding principal balances) together with default interest as provided in the Notes (the “Default Amount”). Additionally, the Holder of the Note, may exercise any other remedy it has under the Note, including that should the Default Amount not be paid within five business days of the March 24, 2014, the Holder of the Note shall in its sole discretion convert the Default Amount into equity as provided for in the Notes.
	As previously reported with the Securities and Exchange Commission, on March 12, 2014, on March 6, 2014, the Company sold a 10% Convertible Redeemable Note in the principal amount of $22,000 (the “March 2014 Note”) pursuant to a Securities Purchase Agreement.   Pursuant to the March 2014 Note, an event of default occurs if the Company defaults under any other note or similar debt instrument. As a result of the of the event of default of the Notes,  interest shall accrue at a default interest rate of 16% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
	Management has evaluated subsequent events through April 25, 2014 the date which these restated financial statements were available to be issued.

Restatement

Restatement	6 Months Ended
	Jan. 31, 2014
Restatement [Abstract]	'
RESTATEMENT	'
	NOTE 8 – RESTATEMENT
	On March 21, 2014, in the process of preparing its quarterly report on Form 10-Q for the quarter ended January 31, 2014, the Company’s management became aware that the Company’s financial statements in the annual report for the year ended July 31, 2012 erroneously did not give effect to shareholder advances for the payment of accounting fees and improperly treated shares issued for services as a liability as opposed to equity.  In addition, the Company determined that during the fiscal year ended July 31, 2013, it had (1) erroneously excluded from the derivative liability valuation a contract entered into late in the fiscal year that allowed for the settlement of the Company’s financial obligations under the contract in the Company’s common stock, based upon the price of the Company’s stock at the time of settlement; and, (2) excluded the value of common stock to be issued for services performed from the financial statements resulting in an understatement of compensation expense.
	The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2013:
		Previously						Current
		Reported			Adjustments			Restatement
	Assets
	Current assets
	Cash	$	23,960		$	-		$	23,960
	Accounts receivable, net		-			-			-
	Inventory		33,766			-			33,766
	Deferred loan costs		26,747			-			26,747
	Total current assets		84,473			-			84,473
	Total assets	$	84,473		$	-		$	84,473
	Liabilities
	Accrued expenses	$	111,467		$	16,417		$	127,884
	Senior secured convertible note payable		402,800			-			402,800
	Derivative Liability		452,912			687,585			1,140,497
	Total current liabilities		967,179			704,200			1,671,181
	Total liabilities		967,179			704,200			1,671,181
	Stockholders' deficit:
	Common stock		121,408			(5,000	)		116,408
	Stock subscription payable		315,600			(61,361	)		254,239
	Additional paid in capital		2,488,564			100,722			2,589,286
	Retained earnings from discontinued operations		6,944			-			6,944
	Accumulated deficit		(3,815,222	)		(738,363	)		(4,553,585	)
	Total stockholders' deficit		(882,706	)		(704,002	)		(1,586,708	)
	Total liabilities and stockholders' deficit	$	84,473		$	-		$	84,473
	Statement of Operations
		Previously			Adjustments			Current
		Reported						Restatement
	Revenue	$	373		$	-		$	373
	Cost of goods sold		1,392			-			1,392
	Gross profit		(1,019	)		-			(1,019	)
	Operating expenses
	General, administrative and other		77,606			4			77,610
	Marketing		10,847			(1	)		10,846
	Compensation		983,292			-			983,292
	Total Operating Expenses		1,071,745			3			1,071,748
	Loss from continuing operations		(1,072,764	)		(3	)		(1,072,767	)
	Other income (expense)
	Change in derivative liability		210,482			687,585			898,067
	Interest expense		209,268			-			209,268
	Total Other (Income) Expense		419,750			687,585			1,107,335
	Net loss	$	(1,492,514	)	$	(687,588	)	$	(2,180,102	)
	Net loss per common share	$	(0.00	)	$	(0.02	)	$	(0.02	)
	The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2013:
		Previously			Adjustments			Current
		Reported						Restatement
	Assets
	Current assets
	Cash	$	3,920		$	-		$	2,529
	Accounts receivable, net		-			-			-
	Inventory		31,034			-			31,034
	Deferred loan costs		174,857			-			174,857
	Total current assets		209,811			-			209,811
	Total assets	$	209,811		$	-		$	209,811
	Liabilities and Stockholders’ Deficit
	Liabilities:
	Accrued expenses	$	60,564		$	16,415		$	76,979
	Convertible notes payable, net		270,000			-			270,000
	Derivative liability		242,430			-			242,430
	Total current liabilities		572,994			16,415			589,409
	Total liabilities		572,994			16,415			589,409
Stockholders' deficit: Common stock		108,970			(5,000	)		103,970
Stock subscription payable		282,220			(61,381	)		220,839
Additional paid in capital		1,561,409			100,723			1,662,132
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(2,322,706	)		(50,777	)		(2,373,483	)
Total stockholders' deficit		(363,183	)		(16,415	)		(379,598	)
Total liabilities and stockholders' deficit	$	209,811		$	-		$	209,811
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenues	$	55,143		$	-		$	55,143
Cost of goods sold		36,411			-			36,411
Gross profit		18,732			-			18,732
Operating expenses
General, administrative and other		502,162			(220	)		501,942
Marketing		982,637			-			982,637
Product development		37,077			-			37,077
Compensation		313,007			50,997			364,004
Total Operating Expenses		1,834,886			50,777			1,885,660
Other expense
Interest expense		120,329			-			120,329
Change in derivative liability		242,430			-			242,430
Loss from continuing operations		(2,178,910	)		(50,777	)		(2,229,687	)
Discontinued operations, net		-			-			-
Net loss	$	(2,178,910	)	$	(50,777	)	$	(2,229,687	)
Net loss per common share	$	(0.02	)	$	(0.00	)	$	(0.02	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the nine months ended April 30, 2013:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Current assets
Cash	$	39,015		$	-		$	39,015
Prepaid expenses		37,042			-			37,042
Inventory		26,587			-			26,587
Deferred loan costs		316,977			-			316,977
Total current assets		419,621			-			419,621
Total assets	$	419,621		$	-		$	419,621
Liabilities:
Accrued expenses	$	44,463		$	16,415		$	60,878
Senior secured convertible note payable		240,000			-			240,000
Total current liabilities		288,463			16,415			300,878
Derivative liability		118,133			-			118,133
Total liabilities		402,596			16,415			419,011
Stockholders' deficit: Common stock		103,970			-			103,970
Stock subscription payable		282,220			(61,361	)		220,859
Additional paid in capital		1,568,130			95,723			1,663,853
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(1,944,239	)		(50,777	)		(1,995,016	)
Total stockholders' deficit		17,025			(16,415	)		610
Total liabilities and stockholders' deficit	$	419,621		$	-		$	419,621
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenues	$	53,283		$	-		$	53,283
Cost of goods sold		35,499			-			35,499
Gross Profit		17,784			-			17,784
Operating expenses
General, administrative and other		368,094			-			368,094
Marketing		970,379			-			970,379
Product development		37,019			-			37,019
Compensation		300,001			50,777			351,778
Total Operating Expenses		1,676,493			50,777			1,727,270
Other income (expense)
Interest expense and finance costs		(23,601	)		-			(23,601	)
Change in derivative liability		(118,133	)		-			(118,133	)
Loss from continuing operations		(1,785,231	)		(50,777	)		1,851,220	)
Discontinued operations, net		-			-			-
Net loss	$	(1,785,231	)	$	(50,777	)	$	(1,851,220	)
Net loss per common share	$	(0.00	)	$	(0.02	)	$	(0.02	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the six months ended January 31, 2013:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Current assets
Cash	$	2,529		$	-		$	2,529
Prepaid expenses		10,861			-			10,861
Inventory		53,377			-			53,377
Deferred loan costs		452,221			-			452,221
Total current assets		518,988			-			518,988
Total assets	$	518,988		$	-		$	518,988
Liabilities:
Accrued expenses	$	21,748		$	32,830		$	54,578
Senior secured convertible note payable		100,000			-			100,000
Total current liabilities		121,748			32,830			154,578
Total liabilities		121,748			32,830			154,578
Stockholders' deficit:
Common stock		97,560			-			94,150
Stock subscription payable		510,000			(61,361	)		448,639
Additional paid in capital		645,242			44,946			690,188
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(862,506	)		(16,415	)		(878,921	)
Total stockholders' deficit		397,420			(32,830	)		364,410
Total liabilities and stockholders' deficit	$	518,988		$	-		$	518,988
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		175,673			-			175,673
Marketing		183,129			-			183,129
Product development		37,019			-			37,019
Compensation		314,500			-			314,500
Total Operating Expenses		710,321			-			710,321
Other income (expense)
Interest expense and finance costs		(8,389	)					(8,389	)
Loss from continuing operations		(718,710	)		-			(718,710	)
Discontinued operations, net		-			-			-
Net loss	$	(718,710	)	$	-		$	(718,710	)
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2012:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Current assets:
Cash	$	2,234		$	2,234		$	2,234
Total current assets		2,234			2,234			2,234
Total assets	$	2,234		$	2,234		$	2,234
Liabilities:
Accrued expenses	$	9,539		$	16,415		$	25,954
Total current liabilities		9,539			16,415			25,954
Liability for Issuable Common Stock		203,361			(203,361	)		-
Total liabilities		212,900			(186,946	)		25,954
Stockholders' deficit:
Common stock		94,150			-			94,150
Additional paid in capital		(22,709	)		44,946			22,237
Stock subscription payable		-			142,000			142,000
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(289,051	)		-			(289,051	)
Total stockholders' deficit		(210,666	)		186,946			(23,720	)
Total liabilities and stockholders' deficit	$	2,234		$	-		$	2,234
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		53,380			-			53,380
Marketing		43,131			-			43,131
Product development		21,744			-			21,744
Compensation		27,000			-			27,000
Total Operating Expenses		145,255			-			145,255
Loss from continuing operations		(145,255	)		-			(145,255	)
Discontinued operations, net		-			-			-
Net loss	$	(145,255	)	$	-		$	(145,255	)
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2012:
Assets	Previously			Adjustments			Current
	Reported						Restatement
Assets	$	-		$	-		$	-
Total assets	$	-		$	-		$	-
Liabilities:
Accrued expenses	$	4,050		$	32,830		$	36,880
Total current liabilities		4,050			32,830			36,880
Liability for Issuable Common Stock		61,361			(61,361	)		-
Total liabilities		65,411			(28,531	)		36,880
Stockholders' deficit:
Common stock		94,150			-			94,150
Additional paid in capital		(22,709	)		44,946			22,237
Retained earnings from discontinued operations		6,944						6,944
Accumulated deficit		(143,796	)		(16,415	)		(160,211	)
Total stockholders' deficit		(65,411	)		(28,531	)		(36,880	)
Total liabilities and stockholders' deficit	$	-		$	-		$	-
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		49,820			16,415			66,235
Marketing		5,863			-			5,863
Product development		45,413			-			45,413
Compensation		20,000			-			20,000
Total Operating Expenses		121,096			16,415			137,511
Loss from continuing operations		(121,096	)		16,415			(137,511	)
Discontinued operations, net		(25	)		-			(25	)
Net loss	$	(121,121	)	$	16,415		$	(137,536	)
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)

Basis_of_Presentation_and_Acco1

Basis of Presentation and Accounting Policies (Policies)	6 Months Ended
	Jan. 31, 2014
Basis of Presentation and Accounting Policies [Abstract]	'
Interim financial statements	'
	Interim financial statements
	The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission set forth in Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Unaudited interim results are not necessarily indicative of the results for the full fiscal year.  These financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended July 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K.
Share-Based Compensation	'
	Share-Based Compensation
	The Company issues stock-based compensation awards to contractors, vendors and for marketing purposes. This compensation is generally in the form of restricted shares of common stock.
	The Company measures and recognizes compensation expense for all stock-based awards based on the awards' fair value which is generally the quoted market value of common shares on the date that the contract mandating the award issuance is executed. The Company recognizes the expense on a straight-line basis over the service period of the related contract. However, if shares of common stock are issued as of the inception of a contract period and the Company does not have the right to recover any of the shares for nonperformance, the entire expense is recognized at the inception date of the contract.
Basic and Diluted Loss Per Common Share	'
	Basic and Diluted Loss Per Common Share
	Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic and diluted net income per common share has been calculated by dividing the net income for the period by the basic and diluted weighted average number of common shares outstanding assuming that the Company incorporated as of the beginning of the first period presented. There were no dilutive shares outstanding at January 31, 2014 or 2012.  Issuable common stock is not included in the calculation of basic or diluted weighted average number of common shares outstanding because including these shares would be antidilutive.
Discontinued Operation	'
	Discontinued Operations
	In accordance with ASC 205-20, Presentation of Financial Statements-Discontinued Operations (“ASC 205-20”), the Company reported the results of its commercial cleaning services as a discontinued operation. The results of operations of business dispositions are   segregated from continuing operations and reflected as discontinued operations in current and prior periods. The application of the principle is discussed in Note 5, Discontinued Operations.
Recently Issued Accounting Standards	'
	Recently Issued Accounting Standards
	There were no new accounting pronouncements that had a significant impact on the Company’s operating results or financial position.

Convetible_Notes_Payable_Table

Convetible Notes Payable (Tables)	6 Months Ended
	Jan. 31, 2014
Convertible Notes Payable [Abstract]	'
Convertible Notes Payable	'
		January 31,			July 31,
	Description	2014			2013
	On November 15, 2012, the Company entered into a Senior Secured Promissory Note (the “Note”) with an unaffiliated party (the “Third Party”) under which the Company received a one-year loan with a principal balance of $100,000. The loan bears interest at 20% per annum with interest payments due quarterly. In addition, the Company issued 2,500,000 shares of restricted common stock to the lender and Mr. Holley and McBride pledged their 56,250,000 shares of the Company’s common stock as collateral and transferred 1,000,000 shares of free trading shares to the lender. If the Company goes into default of the provisions of the loan, it becomes convertible into the Company’s common stock at a price of $0.001 per share (100 million shares). If an event of default occurs, the lender will have the ability of becoming the controlling shareholder of the Company. The Company recorded deferred financing costs of $560,000 in connection with these transfers.  The deferred financing costs is being amortized to interest expense over the term of the loan or twelve months. The company reflected amortization on the deferred financing costs in the amount of $148,111 for the three months ended January 31, 2014, which is reflected in the statement of operations.  On June 20, 2013, the Company and the Third party entered into an Amended and Restated Senior Secured Convertible Promissory Note (the “Amended Note”) which amended certain terms of the Note. Pursuant to the Amended Note, the Company’s repayment of the principal balance of the Amended Note is secured by all the assets of the Company. In addition, the provisions of the Note whereby Mssrs. Holley and McBride pledged 56,250,000 of their shares of common stock of the Company were removed.	$	100,000		$	100,000
	On February 27, 2013, the Company entered into a $335,000 convertible loan agreement. The agreement provides for a $35,000 original issue discount. The lender, at its discretion, may provide funds up to $300,000 to the Company. It provided $60,000 at the closing of the agreement on April 30, 2013. All loans under the agreement are payable in full one year after the funds are issued together with a prorated portion of the original issue discount. All amounts outstanding under the agreement become convertible, at the lender’s discretion, into shares of the Company’s common stock starting 180 days from the execution date of the agreement. The conversion rate per share is the lower of (i) $0.044 or (ii) 60% of the lowest trade price during the 25 trading days prior to a conversion notice. The lender has agreed that it will not execute any short trades and, at no time, will hold more than 4.9% of the Company’s outstanding common stock.		92,800			115,000
	If the Company repays all amounts outstanding under the agreement within 90 days of the execution date, there will be no interest amounts due. If it does not pay all amounts due within 90 days of the execution date, it cannot make any other prepayments of the amounts outstanding without the consent of the lender. In addition, there will be a one-time interest charge of 12% of the amounts outstanding. The Company must also register all shares that are issuable under the agreement in any Registration Statement that it files with the SEC for any purpose.
	On April 30, 2013, the Company sold an 18% Senior Convertible Debenture in the principal amount of $60,000 (the “Debenture”). The Debenture matures on April 30, 2014 and has an interest rate of 18% per annum payable monthly and on each conversion date. The conversion price of the Debenture is 65% of the average of the lowest three closing bid prices of the Common Stock for the twenty trading days immediately prior to the conversion date.		40,000			55,000
	Upon an Event of Default (as defined in the Debenture), the outstanding principal amount of the Debenture plus accrued but unpaid interest, liquidated damages and other amounts owing on the Debenture through the date of the acceleration shall become at the Debenture holder’s election immediately due and payable in cash at the Mandatory Default Amount (as defined in the Debenture). Commencing five days after the occurrence of an Event of Default that results in the eventual acceleration of the Debenture, the interest rate on the Debenture shall accrue at an interest rate equal to the lesser of 22% per annum or the maximum rate permitted under applicable law.
	In connection with the sale of the Debenture, on April 30, 2013 (the “Initial Exercise Date”) the Company issued the purchaser of the Debenture a warrant to purchase 3,726,708 shares of the Company’s common stock at an exercise price of $.03 per share (subject to adjustment as provided in the debenture). The Warrant is exercisable on a cashless basis (as provided in the Warrant) and as a result there is no assurance that any part of the Warrant will be exercised for cash. The warrant terminates three years from the Initial Exercise Date and on such date the Warrant shall be automatically exercised via cashless exercise. The fair market value of the warrant was $50,777 on the date of issuance.
	On October 10, 2013, Dethrone Royalty Holdings, Inc. (the “Company”), entered into a securities purchase agreement (the “SPA”) with an investor (“Investor”), pursuant to which the Investor purchased a master promissory note (the “Master Note”) with a principal balance of $48,000 for a purchase price of $40,000 at an original issuance discount of $4,000.  The Company also agreed to pay $4,000 worth of legal, accounting and due diligence costs to the Investor.		48,000			-
	Pursuant to the Master Note, the Investor has the right, solely in the Investor’s discretion, to subsequently purchase up to eight (8) additional promissory notes (each, an “Additional Note”, the Master Note and each Additional Note collectively, the “Notes”), at any time from the date of issuance of the Master Note until October 10, 2014.  Each Additional Note shall have a principal balance of $22,000 and shall have a purchase price of $20,000, at an original issue discount of $2,000.
	Pursuant to the Master Note, if the Company repays the entire balance of each Note prior to the Prepayment Opportunity Date (as defined in the Master Note), the Company shall pay an interest rate equal to 0% per annum.  If the Company does not repay the entire balance of each Note prior to the Prepayment Opportunity Date (as defined in the Master Note) each Note shall have a one-time interest charge equal to 12% , applied to the outstanding balance of each note.
	Each Note is convertible, at any time after the date six months from the Purchase Price Date (as defined in the Master Note), into shares of the Company’s common stock at an exercise price equal to (i) the outstanding balance divided by (ii) 60% of the lowest intra-day trade price in the twenty-five (25) trading days immediately preceding the conversion, subject to certain adjustment as further described in the Master Note (the “Conversion Price”).
	In connection with the SPA and the issuance of the Master Note, the Company issued to the Investor, warrants to purchase shares of the Company’s common stock (the “Warrant”) at an exercise price equal to the Conversion Price.  The Warrant has a term of five years.  The warrant provides for both cash and cashless exercise. The fair value of the warrant on the date of issuance was $295,273.
	8% Convertible Note, dated August 26, 2013, in the principal amount of $42,500 (the “Note”) pursuant to a Securities Purchase Agreement. The Note matures on May 21, 2014 and has an interest rate of 8% per annum until the Note becomes due. Any amount of principal or interest on the Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof.		42,500			-
	The Note may be converted into common stock of the Company at any time beginning on the 180 th day of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.
	If the Company fails to pay the principal hereof or interest thereon when due at the maturity date, the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the Default Sum (as defined in the Note). If the Company fails to issue common stock of the Company upon exercise of the Note, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum multiplied by two. Upon any other Event of Default (as defined in the Note), the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the greater of (i) 150% times the Default Sum or (ii) the “parity value” (as defined in the Note) of the Default Sum to be prepaid.
	On October 1, 2013, the Company, sold an 8% Convertible Note in the principal amount of $32,500 (the “Note”) pursuant to a Securities Purchase Agreement. The Note matures on June 19, 2014 and has an interest rate of 8% per annum until the Note becomes due. Any amount of principal or interest on the Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof.		32,500			-
	The Note may be converted into common stock of the Company at any time beginning on the 180 th day of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.
	If the Company fails to pay the principal hereof or interest thereon when due at the maturity date, the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the Default Sum (as defined in the Note). If the Company fails to issue common stock of the Company upon exercise of the Note, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum multiplied by two. Upon any other Event of Default (as defined in the Note), the Note shall become immediately due and payable and the Company shall pay to the holder of the Note an amount equal to the greater of (i) 150% times the Default Sum or (ii) the “parity value” (as defined in the Note) of the Default Sum to be prepaid.
	On January 8, 2014, the Company sold a note with a principal balance of $75,000 for a purchase price of $50,000 at an original issuance discount of $25,000.  (the “January 2014 Note”).  The January 2014 Note matures on July 8, 2014.		75,000			-
	Original issued discount		(25,000	)		-
	Beneficial conversion feature		(75,000	)		-
	Less: Amortization of discounts		11,148			-
	Total convertible notes payable	$	366,948		$	270,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	6 Months Ended
	Jan. 31, 2014
Commitments and Contingencies [Abstract]	'
Summary of license agreement	'
	Year		Royalty
	1		12% of Gross Profit
	2		$50,000 plus 8% of Gross Profit
	3		$100,000 or 6% of Gross profit, whichever is higher
	4		$150,000 or 6% of Gross profit, whichever is higher
	5		$200,000 or 6% of Gross profit, whichever is high
Schedule of minimum levels of sales	'
	Year	Minimum Sales
	1	$	-0-
	2	$	3,000,000
	3	$	6,000,000
	4	$	9,000,000
	5	$	12,000,000
Summary of minimum royalties payment	'
		Time Period:		Minimum		Minimum
				Net		Quarterly
				Revenue		Payments
	(a)	Effective Date through 12/31/13			0		N/A
	(b)	01/01/14 through 12/31/14			1,000,000.00		37,500.00
	(c)	01/01/15 through 12/31/15			1,600,000.00		50,000.00
	(d)	01/01/16 through 12/31/16			2,500,000.00		75,000.00
	* 2015 minimum Net Revenue shall be the greater of 120% of the actual 2014 Net Revenue or $1,600,000.00.
	*** 2016 Minimum Net Revenue shall be the greater of 110% of the actual 2015 Net Revenue or $2,500,000.00. During any Extension Term and beyond 2016, the annual Minimum Net Revenue shall be at least 105% greater than the previous year.

Restatement_Tables

Restatement (Tables)	6 Months Ended
	Jan. 31, 2014
Restatement [Abstract]	'
Reconciliation of Consolidated Balance Sheet	'
	The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2013:
		Previously			Adjustments			Current
		Reported						Restatement
	Assets
	Current assets
	Cash	$	23,960		$	-		$	23,960
	Accounts receivable, net		-			-			-
	Inventory		33,766			-			33,766
	Deferred loan costs		26,747			-			26,747
	Total current assets		84,473			-			84,473
	Total assets	$	84,473		$	-		$	84,473
	Liabilities
	Accrued expenses	$	111,467		$	16,417		$	127,884
	Senior secured convertible note payable		402,800			-			402,800
	Derivative Liability		452,912			687,585			1,140,497
	Total current liabilities		967,179			704,200			1,671,181
	Total liabilities		967,179			704,200			1,671,181
	Stockholders' deficit:
	Common stock		121,408			(5,000	)		116,408
	Stock subscription payable		315,600			(61,361	)		254,239
	Additional paid in capital		2,488,564			100,722			2,589,286
	Retained earnings from discontinued operations		6,944			-			6,944
	Accumulated deficit		(3,815,222	)		(738,363	)		(4,553,585	)
	Total stockholders' deficit		(882,706	)		(704,002	)		(1,586,708	)
	Total liabilities and stockholders' deficit	$	84,473		$	-		$	84,473
	The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2013:
		Previously			Adjustments			Current
		Reported						Restatement
	Assets
	Current assets
	Cash	$	3,920		$	-		$	2,529
	Accounts receivable, net		-			-			-
	Inventory		31,034			-			31,034
	Deferred loan costs		174,857			-			174,857
	Total current assets		209,811			-			209,811
	Total assets	$	209,811		$	-		$	209,811
	Liabilities and Stockholders’ Deficit
	Liabilities:
	Accrued expenses	$	60,564		$	16,415		$	76,979
	Convertible notes payable, net		270,000			-			270,000
	Derivative liability		242,430			-			242,430
	Total current liabilities		572,994			16,415			589,409
	Total liabilities		572,994			16,415			589,409
	Stockholders' deficit:
	Common stock		108,970			(5,000	)		103,970
	Stock subscription payable		282,220			(61,381	)		220,839
	Additional paid in capital		1,561,409			100,723			1,662,132
	Retained earnings from discontinued operations		6,944			-			6,944
	Accumulated deficit		(2,322,706	)		(50,777	)		(2,373,483	)
	Total stockholders' deficit		(363,183	)		(16,415	)		(379,598	)
	Total liabilities and stockholders' deficit	$	209,811		$	-		$	209,811
	The following tables summarize the effect of corrections on the consolidated financial statements as of the nine months ended April 30, 2013:
		Previously			Adjustments			Current
		Reported						Restatement
	Assets
	Current assets
	Cash	$	39,015		$	-		$	39,015
	Prepaid expenses		37,042			-			37,042
	Inventory		26,587			-			26,587
	Deferred loan costs		316,977			-			316,977
	Total current assets		419,621			-			419,621
	Total assets	$	419,621		$	-		$	419,621
	Liabilities:
Accrued expenses	$	44,463		$	16,415		$	60,878
Senior secured convertible note payable		240,000			-			240,000
Total current liabilities		288,463			16,415			300,878
Derivative liability		118,133			-			118,133
Total liabilities		402,596			16,415			419,011
Stockholders' deficit:
Common stock		103,970			-			103,970
Stock subscription payable		282,220			(61,361	)		220,859
Additional paid in capital		1,568,130			95,723			1,663,853
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(1,944,239	)		(50,777	)		(1,995,016	)
Total stockholders' deficit		17,025			(16,415	)		610
Total liabilities and stockholders' deficit	$	419,621		$	-		$	419,621
The following tables summarize the effect of corrections on the consolidated financial statements as of the six months ended January 31, 2013:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Current assets
Cash	$	2,529		$	-		$	2,529
Prepaid expenses		10,861			-			10,861
Inventory		53,377			-			53,377
Deferred loan costs		452,221			-			452,221
Total current assets		518,988			-			518,988
Total assets	$	518,988		$	-		$	518,988
Liabilities:
Accrued expenses	$	21,748		$	32,830		$	54,578
Senior secured convertible note payable		100,000			-			100,000
Total current liabilities		121,748			32,830			154,578
Total liabilities		121,748			32,830			154,578
Stockholders' deficit:
Common stock		97,560			-			94,150
Stock subscription payable		510,000			(61,361	)		448,639
Additional paid in capital		645,242			44,946			690,188
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(862,506	)		(16,415	)		(878,921	)
Total stockholders' deficit		397,420			(32,830	)		364,410
Total liabilities and stockholders' deficit	$	518,988		$	-		$	518,988
The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2012:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Current assets:
Cash	$	2,234		$	2,234		$	2,234
Total current assets		2,234			2,234			2,234
Total assets	$	2,234		$	2,234		$	2,234
Liabilities:
Accrued expenses	$	9,539		$	16,415		$	25,954
Total current liabilities		9,539			16,415			25,954
Liability for Issuable Common Stock		203,361			(203,361	)		-
Total liabilities		212,900			(186,946	)		25,954
Stockholders' deficit: Common stock		94,150			-			94,150
Additional paid in capital		(22,709	)		44,946			22,237
Stock subscription payable		-			142,000			142,000
Retained earnings from discontinued operations		6,944			-			6,944
Accumulated deficit		(289,051	)		-			(289,051	)
Total stockholders' deficit		(210,666	)		186,946			(23,720	)
Total liabilities and stockholders' deficit	$	2,234		$	-		$	2,234
The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2012:
	Previously			Adjustments			Current
	Reported						Restatement
Assets
Assets	$	-		$	-		$	-
Total assets	$	-		$	-		$	-
Liabilities:
Accrued expenses	$	4,050		$	32,830		$	36,880
Total current liabilities		4,050			32,830			36,880
Liability for Issuable Common Stock		61,361			(61,361	)		-
Total liabilities		65,411			(28,531	)		36,880
Stockholders' deficit:
Common stock		94,150			-			94,150
Additional paid in capital		(22,709	)		44,946			22,237
Retained earnings from discontinued operations		6,944						6,944
Accumulated deficit		(143,796	)		(16,415	)		(160,211	)
Total stockholders' deficit		(65,411	)		(28,531	)		(36,880	)
Total liabilities and stockholders' deficit	$	-		$	-		$	-
Reconciliation of Consolidated statements of operations and comprehensive loss	'
	The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2013:
	Statement of Operations
		Previously			Adjustments			Current
		Reported						Restatement
	Revenue	$	373		$	-		$	373
	Cost of goods sold		1,392			-			1,392
	Gross profit		(1,019	)		-			(1,019	)
	Operating expenses
	General, administrative and other		77,606			4			77,610
	Marketing		10,847			(1	)		10,846
	Compensation		983,292			-			983,292
	Total Operating Expenses		1,071,745			3			1,071,748
	Loss from continuing operations		(1,072,764	)		(3	)		(1,072,767	)
	Other income (expense)
	Change in derivative liability		210,482			687,585			898,067
	Interest expense		209,268		-				209,268
	Total Other (Income) Expense		419,750			687,585			1,107,335
	Net loss	$	(1,492,514	)	$	(687,588	)	$	(2,180,102	)
	Net loss per common share	$	(0.00	)	$	(0.02	)	$	(0.02	)
	The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2013:
	Statement of Operations
		Previously			Adjustments			Current
		Reported						Restatement
	Revenues	$	55,143		$	-		$	55,143
	Cost of goods sold		36,411			-			36,411
	Gross profit		18,732			-			18,732
	Operating expenses
	General, administrative and other		502,162			(220	)		501,942
	Marketing		982,637			-			982,637
	Product development		37,077			-			37,077
	Compensation		313,007			50,997			364,004
	Total Operating Expenses		1,834,886			50,777			1,885,660
	Other expense
	Interest expense		120,329			-			120,329
	Change in derivative liability		242,430			-			242,430
	Loss from continuing operations		(2,178,910	)		(50,777	)		(2,229,687	)
	Discontinued operations, net		-			-			-
	Net loss	$	(2,178,910	)	$	(50,777	)	$	(2,229,687	)
	Net loss per common share	$	(0.02	)	$	(0.00	)	$	(0.02	)
	The following tables summarize the effect of corrections on the consolidated financial statements as of the nine months ended April 30, 2013:
	Statement of Operations
		Previously			Adjustments			Current
		Reported						Restatement
	Revenues	$	53,283		$	-		$	53,283
	Cost of goods sold		35,499			-			35,499
	Gross Profit		17,784			-			17,784
	Operating expenses
	General, administrative and other		368,094			-			368,094
	Marketing		970,379			-			970,379
	Product development		37,019			-			37,019
	Compensation		300,001			50,777			351,778
	Total Operating Expenses		1,676,493			50,777			1,727,270
	Other income (expense)
	Interest expense and finance costs		(23,601	)		-			(23,601	)
	Change in derivative liability		(118,133	)		-			(118,133	)
	Loss from continuing operations		(1,785,231	)		(50,777	)		1,851,220	)
	Discontinued operations, net		-			-			-
	Net loss	$	(1,785,231	)	$	(50,777	)	$	(1,851,220	)
	Net loss per common share	$	(0.00	)	$	(0.02	)	$	(0.02	)
	The following tables summarize the effect of corrections on the consolidated financial statements as of the six months ended January 31, 2013:
	Statement of Operations
		Previously			Adjustments			Current
		Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		175,673			-			175,673
Marketing		183,129			-			183,129
Product development		37,019			-			37,019
Compensation		314,500			-			314,500
Total Operating Expenses		710,321			-			710,321
Other income (expense)
Interest expense and finance costs		(8,389	)					(8,389	)
Loss from continuing operations		(718,710	)		-			(718,710	)
Discontinued operations, net		-			-			-
Net loss	$	(718,710	)	$	-		$	(718,710	)
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2012:
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		53,380			-			53,380
Marketing		43,131			-			43,131
Product development		21,744			-			21,744
Compensation		27,000			-			27,000
Total Operating Expenses		145,255			-			145,255
Loss from continuing operations		(145,255	)		-			(145,255	)
Discontinued operations, net		-			-			-
Net loss	$	(145,255	)	$	-		$	(145,255
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)
The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2012:
Statement of Operations
	Previously			Adjustments			Current
	Reported						Restatement
Revenue	$	-		$	-		$	-
Operating expenses
General, administrative and other		49,820			16,415			66,235
Marketing		5,863			-			5,863
Product development		45,413			-			45,413
Compensation		20,000			-			20,000
Total Operating Expenses		121,096			16,415			137,511
Loss from continuing operations		(121,096	)		16,415			(137,511	)
Discontinued operations, net		(25	)		-			(25	)
Net loss	$	(121,121	)	$	16,415		$	(137,536	)
Net loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)	Jan. 31, 2014	Oct. 31, 2013	Jul. 31, 2013	Apr. 30, 2013	Jan. 31, 2013
Net of discount on convertible notes payable	$88,852	'	$0	'	'
Beneficial conversion feature	-75,000	'	'	'	'
Less: Amortization of discounts	11,148	'	'	'	'
Total convertible notes payable	366,948	402,800	270,000	240,000	100,000
Note 1	'	'	'	'	'
Convertible Notes Payable	100,000	'	100,000	'	'
Note 2	'	'	'	'	'
Convertible Notes Payable	92,800	'	115,000	'	'
Net of discount on convertible notes payable	35,000	'	'	'	'
Note 3	'	'	'	'	'
Convertible Notes Payable	40,000	'	55,000	'	'
Note 4	'	'	'	'	'
Convertible Notes Payable	48,000	'	'	'	'
Net of discount on convertible notes payable	4,000	'	'	'	'
Note 5	'	'	'	'	'
Convertible Notes Payable	42,500	'	'	'	'
Note 6	'	'	'	'	'
Convertible Notes Payable	32,500	'	'	'	'
Note 7	'	'	'	'	'
Convertible Notes Payable	75,000	'	'	'	'
Net of discount on convertible notes payable	$25,000	'	'	'	'

Convertible_Notes_Payable_Deta1

Convertible Notes Payable (Details) (Parenthetical) (USD $)	6 Months Ended			3 Months Ended	6 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Jul. 31, 2013	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014
				Note 1	Note 1	Note 2	Note 3	Note 4	Note 5	Note 6	Note 7
Issue Date	'	'	'	'	15-Nov-12	27-Feb-13	30-Apr-13	10-Oct-13	26-Aug-13	1-Oct-13	8-Jan-14
Description	'	'	'	'	'	'	'18% Senior Convertible Debenture	'	'8% Convertible Note	'8% Convertible Note	'
					Senoir Secured Promissory Note	Convertible loan agreement.		MasterNote
Principal amount	'	'	'	$100,000	$100,000	$335,000	$60,000	$48,000	$42,500	$32,500	$75,000
Purchase price of note	'	'	'	'	'	'	'	40,000	'	'	50,000
Net of discount on convertible notes payable	88,852	'	0	'	'	35,000	'	4,000	'	'	25,000
Debt Expense	'	'	'	'	'	'	'	4,000	'	'	'
Funds Capacity	'	'	'	'	'	300,000	'	'	'	'	'
Funds Provided by loan	'	'	'	'	'	60,000	'	'	'	'	'
Interest Rate per annum	'	'	'	20.00%	20.00%	12.00%	18.00%	0.00%	8.00%	8.00%	'
Date of Maturity	'	'	'	'	'	'	30-Apr-14	'	'	19-Jun-14	8-Jul-14
Common stock issued for debt	'	'	'	'	2,500,000	'	'	'	'	'	'
Collateral	'	'	'	'	'56,250,000 shares	'	'	'	'	'	'
Common stock transferred	'	'	'	'	1,000,000	'	'	'	'	'	'
Conversion Price per share	'	'	'	$0.00	$0.00	$0.04	$0.03	'	'	'	'
Amortization of deferred financing costs	174,857	107,779	'	148,111	'	'	'	'	'	'	'
Convertible shares	'	'	'	'	'	'	'	'	'	'	'
					100 million shares		3,726,708
Deferred financing costs	'	'	'	560,000	560,000	'	'	'	'	'	'
Fair market value of the warrant	'	'	'	'	'	'	$50,777	$295,273	'	'	'

Convertible_Notes_Payable_Deta2

Convertible Notes Payable (Details) (Parenthetical 1)	6 Months Ended
	Jan. 31, 2014
Note 1	'
Default clause	'Lender will have the ability of becoming the controlling shareholder of the Company.
Note 2	'
Default clause	'One-time interest charge of 12% of the amounts outstanding.
Convertible terms	'60% of the lowest trade price during the 25 trading days prior to a conversion notice.
Note 3	'
Default clause	'
	22% per annum or the maximum rate permitted under applicable law
Convertible terms	'65% of the average of the lowest three closing bid prices of the Common Stock for the twenty trading days immediately prior to the conversion date.
Note 4	'
Default clause	'
	12% , applied to the outstanding balance of each note
Convertible terms	'
	Each Note is convertible, at any time after the date six months from the Purchase Price Date (as defined in the Master Note), into shares of the Company’s common stock at an exercise price equal to (i) the outstanding balance divided by (ii) 60% of the lowest intra-day trade price in the twenty-five (25) trading days immediately preceding the conversion, subject to certain adjustment as further described in the Master Note (the“Conversion Price”).
Note 5	'
Default clause	'
	Any amount ofprincipal or interest on the note which is not paid when due shall bear interest at the rate of 22% per annum from the due datethereof.
Convertible terms	'
	The Note may be converted into common stock of the Company at any time beginning on the 180thday of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.
Note 6	'
Default clause	'
	Any amount ofprincipal or interest on the note which is not paid when due shall bear interest at the rate of 22% per annum from the due datethereof.
Convertible terms	'
	The Note may be converted into common stock of the Company at any time beginning on the 180thday of the date of the Note. However, the Note shall not be converted if the conversion would result in beneficial ownership by the holder of the Note and its affiliates to own more than 9.99% of the outstanding shares of the Company’s common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days’ prior notice to the Company. The conversion price is 58% of the average of the lowest three closing bid prices of the Company’s common stock for the ten trading days immediately prior to the conversion date.

Derivative_Liability_Details

Derivative Liability (Details) (USD $)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jan. 31, 2014	Oct. 31, 2013	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013	Apr. 30, 2013	Jul. 31, 2013
Derivative Liability [Abstract]	'	'	'	'	'	'	'
Variable conversion feature, derivative liability	'	'	'	'	'	'	$235,165
Variable conversion feature, change in derivative liability	'	'	'	'	'	'	7,265
Derivative liability	899,350	1,140,497	'	899,350	'	118,133	242,430
Increase (decrease) in derivative liability	($241,147)	$898,067	'	$656,920	'	($118,133)	$242,430

Equity_Details

Equity (Details) (USD $)	1 Months Ended
	Jan. 31, 2014	Nov. 30, 2013	Oct. 31, 2013	Aug. 31, 2013
Equity [Abstract]	'	'	'	'
Debt conversion, amount	$22,000	'	$5,000	$10,200
Debt conversion, shares issued	16,000,000	'	5,000,000	2,000,000
Common stock for services, Value	26,000	1,500	924,393	'
Expenses related to celebrity endorsement contracts	$6,000	'	'	'
Increase in shares issuable in the Stock Subscriptions account	300,000	'	'	'

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	6 Months Ended
	Jan. 31, 2014
Year 1	'
Percentage of Gross profit	12.00%
Royalty fee	'
Minimum Sales	0
Year 2	'
Percentage of Gross profit	8.00%
Royalty fee	50,000
Minimum Sales	3,000,000
Year 3	'
Percentage of Gross profit	6.00%
Royalty fee	100,000
Minimum Sales	6,000,000
Year 4	'
Percentage of Gross profit	6.00%
Royalty fee	150,000
Minimum Sales	9,000,000
Year 5	'
Percentage of Gross profit	6.00%
Royalty fee	200,000
Minimum Sales	$12,000,000

Commitments_and_Contingencies_2

Commitments and Contingencies (Details 1) (USD $)	6 Months Ended
	Jan. 31, 2014
Common stock issued, shares	$5,437,603
Share price	$0.03
Effective Date through 12/31/13	'
Minimum Net Revenue	0
Minimun Quarterly Payments	0
01/01/14 through 12/31/14	'
Minimum Net Revenue	1,000,000
Minimun Quarterly Payments	37,500
01/01/15 through 12/31/15	'
Minimum Net Revenue	1,600,000	[1]
Minimun Quarterly Payments	50,000	[1]
01/01/16 through 12/31/16	'
Minimum Net Revenue	2,500,000	[2]
Minimun Quarterly Payments	$75,000	[2]
[1]	2015 minimum Net Revenue shall be the greater of 120% of the actual 2014 Net Revenue or $1,600,000.00.
[2]	2016 Minimum Net Revenue shall be the greater of 110% of the actual 2015 Net Revenue or $2,500,000.00. During any Extension Term and beyond 2016, the annual Minimum Net Revenue shall be at least 105% greater than the previous year.

Commitments_and_Contingencies_3

Commitments and Contingencies (Details Textual) (USD $)	6 Months Ended
	Jan. 31, 2014
Percentage of consideration for license on revenue generated	10.00%
License agreement expiration term	'The License Agreement has an initial term of three (3) years and is automatically extended for one (1) additional three (3) year period unless either party elects not to extend the term.
Percentage of compensation paid for for athlete endorser participation	25.00%
Dethrone Royalty	'
Date	'10/14/2013
Allegations	'
	Termination of this license agreement.
License fees demanded	475,000
Alleged Damages	850,000
Overtime Marketing	'
Allegations	'5,000,000 shares of its restricted common stock in exchange for certain marketing services
Alleged Damages	4,814,500
Delaware Limited Liability Company [Member]	'
Shares issued for services	5,437,603
Stock price	0.03

Subsequent_Events_Details

Subsequent Events (Details) (Subsequent Event [Member], USD $)	0 Months Ended
	Mar. 24, 2014	Mar. 06, 2014	Feb. 14, 2014	Jan. 22, 2014	Oct. 01, 2014	Aug. 26, 2014
Subsequent Event [Member]	'	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'	'
Principal amount	'	$22,000	$75,000	$75,000	$32,500	$42,500
Interest rate	'	10.00%	'	'	8.00%	8.00%
Issuance date	'	28-Feb-15	11-Feb-14	8-Jan-14	'	'
Maturity date	'	'	11-Aug-14	8-Jul-14	'	'
Debt issuance cash consideration	'	'	50,000	50,000	'	'
Late fee percentage	'	'	22.00%	22.00%	'	'
Debt instrument principal prepay amount	'	'	75,000	100,000	'	'
Conversion price	'	'	$0.00	$0.00	'	'
Conversion price if company loses the bid	'	'	$0.00	$0.00	'	'
Outstanding principal balance	$113,625	'	'	'	'	'
Percentage of outstanding principal balance	150.00%	'	'	'	'	'
Default interest rate	'	16.00%	'	'	'	'
Debt instrument, convertible terms	'	'The Note may be converted into common stock of the Company at any time beginning on the 180th day of the date of the Note at a price equal to 50% of the lowest closing bid price of the common stock as reported on OTCQB, for the fifteen prior trading days. In the event the Company experiences a DTC "Chill" on its shares, the conversion price shall be decreased to 40% instead of 50% while that "Chill" is in effect.	'The Note shall not be converted to the extent that such conversion would result in beneficial ownership by the holder and its affiliates to own more than 4.99% of the issued and outstanding shares of the Company's common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days' prior notice to the Company.	'The Note shall not be converted to the extent that such conversion would result in beneficial ownership by the holder and its affiliates to own more than 4.99% of the issued and outstanding shares of the Company's common stock. Such limitations on conversion may be waived by the Note holder upon with not less than 61 days' prior notice to the Company.	'	'

Restatement_Details

Restatement (Details) (USD $)	Jan. 31, 2014	Oct. 31, 2013	Jul. 31, 2013	Apr. 30, 2013	Jan. 31, 2013	Oct. 31, 2012	Jul. 31, 2012
Current Assets	'	'	'	'	'	'	'
Cash	$12,403	$23,960	$3,920	$39,015	$2,529	$2,234	'
Accounts receivable, net	'	'	'	'	'	'	'
Prepaid expenses	'	'	'	37,042	10,861	'	'
Inventory	31,149	33,766	31,034	26,587	53,377	'	'
Deferred loan costs	'	26,747	174,857	316,977	452,221	'	'
Total current assets	43,552	84,473	209,811	419,621	518,988	2,234	'
Total assets	43,552	84,473	209,811	419,621	518,988	2,234	'
Current Liabilities	'	'	'	'	'	'	'
Accrued expenses	143,052	127,884	76,979	60,878	54,578	25,954	36,880
Senior secured convertible note payable	366,948	402,800	270,000	240,000	100,000	'	'
Derivative liability	899,350	1,140,497	242,430	118,133	'	'	'
Total current liabilities	1,409,350	1,671,181	589,409	300,878	154,578	25,954	36,880
Liability for Issuable Common Stock	'	'	'	'	'	'	'
Total liabilities	1,409,350	1,671,181	589,409	419,011	154,578	25,954	36,880
Stockholders' Deficit	'	'	'	'	'	'	'
Common stock	134,583	116,408	103,970	103,970	94,150	94,150	94,150
Stock subscriptions payable	260,239	254,239	220,839	220,859	448,639	142,000	'
Additional paid-in capital	2,695,611	2,589,286	1,662,132	1,663,853	690,188	22,237	22,237
Retained earnings from discontinued operations	6,944	6,944	6,944	6,944	6,944	6,944	6,944
Accumulated deficit	-4,463,175	-4,553,585	-2,373,483	-1,995,016	-878,921	-289,051	-160,211
Total stockholders' deficit	-1,365,798	-1,586,708	-379,598	610	364,410	-23,720	-36,880
Total liabilities and stockholders' deficit	43,552	84,473	209,811	419,621	518,988	2,234	'
Previously Reported [Member]	'	'	'	'	'	'	'
Current Assets	'	'	'	'	'	'	'
Cash	'	23,960	3,920	39,015	2,529	2,234	'
Accounts receivable, net	'	'	'	'	'	'	'
Prepaid expenses	'	'	'	37,042	10,861	'	'
Inventory	'	33,766	31,034	26,587	53,377	'	'
Deferred loan costs	'	26,747	174,857	316,977	452,221	'	'
Total current assets	'	84,473	209,811	419,621	518,988	2,234	'
Total assets	'	84,473	209,811	419,621	518,988	2,234	'
Current Liabilities	'	'	'	'	'	'	'
Accrued expenses	'	111,467	60,564	44,463	21,748	9,539	4,050
Senior secured convertible note payable	'	402,800	270,000	240,000	100,000	'	'
Derivative liability	'	452,912	242,430	118,133	'	'	'
Total current liabilities	'	967,179	572,994	288,463	121,748	9,539	4,050
Liability for Issuable Common Stock	'	'	'	'	'	203,361	61,361
Total liabilities	'	967,179	572,994	402,596	121,748	212,900	65,411
Stockholders' Deficit	'	'	'	'	'	'	'
Common stock	'	121,408	108,970	103,970	97,560	94,150	94,150
Stock subscriptions payable	'	315,600	282,220	282,220	510,000	'	'
Additional paid-in capital	'	2,488,564	1,561,409	1,568,130	645,242	-22,709	-22,709
Retained earnings from discontinued operations	'	6,944	6,944	6,944	6,944	6,944	6,944
Accumulated deficit	'	-3,815,222	-2,322,706	-1,944,239	-862,506	-289,051	-143,796
Total stockholders' deficit	'	-882,706	-363,183	17,025	397,420	-210,666	-65,411
Total liabilities and stockholders' deficit	'	84,473	209,811	419,621	518,988	2,234	'
Adjustments [Member]	'	'	'	'	'	'	'
Current Assets	'	'	'	'	'	'	'
Cash	'	'	'	'	'	2,234	'
Accounts receivable, net	'	'	'	'	'	'	'
Prepaid expenses	'	'	'	'	'	'	'
Inventory	'	'	'	'	'	'	'
Deferred loan costs	'	'	'	'	'	'	'
Total current assets	'	'	'	'	'	2,234	'
Total assets	'	'	'	'	'	2,234	'
Current Liabilities	'	'	'	'	'	'	'
Accrued expenses	'	16,417	16,415	16,415	32,830	16,415	32,830
Senior secured convertible note payable	'	'	'	'	'	'	'
Derivative liability	'	687,585	'	'	'	'	'
Total current liabilities	'	704,200	16,415	16,415	32,830	16,415	32,830
Liability for Issuable Common Stock	'	'	'	'	'	-203,361	-61,361
Total liabilities	'	704,200	16,415	16,415	32,830	-186,946	-28,531
Stockholders' Deficit	'	'	'	'	'	'	'
Common stock	'	-5,000	-5,000	'	'	'	'
Stock subscriptions payable	'	-61,361	-61,381	-61,361	-61,361	142,000	'
Additional paid-in capital	'	100,722	100,723	95,723	44,946	44,946	44,946
Retained earnings from discontinued operations	'	'	'	'	'	'	'
Accumulated deficit	'	-738,363	-50,777	-50,777	-16,415	'	-16,415
Total stockholders' deficit	'	-704,002	-16,415	-16,415	-32,830	186,946	-28,531
Total liabilities and stockholders' deficit	'	'	'	'	'	'	'

Restatement_Details_1

Restatement (Details 1) (USD $)	3 Months Ended				6 Months Ended		9 Months Ended	12 Months Ended
	Jan. 31, 2014	Oct. 31, 2013	Jan. 31, 2013	Oct. 31, 2012	Jan. 31, 2014	Jan. 31, 2013	Apr. 30, 2013	Jul. 31, 2013	Jul. 31, 2012
Revenue	$1,108	$373	'	'	$1,481	'	$53,283	$55,143	'
Cost of goods sold	2,971	1,392	'	'	4,363	'	35,499	36,411	'
Gross Profit	-1,863	-1,019	'	'	-2,882	'	17,784	18,732	'
Operating expenses	'	'	'	'	'	'	'	'	'
General, administrative and other	19,151	77,610	122,293	53,380	96,761	175,673	368,094	501,942	66,235
Marketing	7,314	10,846	139,998	43,131	14,392	183,129	970,379	982,637	5,863
Product development	'	'	15,275	21,744	'	37,019	37,019	37,077	45,413
Compensation	52,932	983,292	12,500	27,000	1,039,992	314,500	351,778	364,004	20,000
Total Operating Expenses	79,397	1,071,748	290,066	145,255	1,151,145	710,321	1,727,270	1,885,660	137,511
Interest expense and finance costs	'	'	'	'	'	-8,389	-23,601	'	'
Loss from continuing operations	'	-1,072,767	'	-145,255	-1,072,767	-718,710	1,851,220	-2,229,687	-137,511
Discontinued operations, net	'	'	'	'	'	'	'	'	-25
Other income (expense)	'	'	'	'	'	'	'	'	'
Change in fair value of derivative liability	-241,147	898,067	'	'	656,920	'	-118,133	242,430	'
Interest Expense	53,062	209,268	8,389	'	262,330	8,389	'	120,329	'
Total Other Expenses	-188,085	1,107,335	8,389	'	919,250	8,389	'	'	'
Net (loss)	106,825	-2,180,102	-298,455	-145,255	-2,073,277	-718,710	-1,851,220	-2,229,687	-137,536
Net loss per common share	$0	($0.02)	$0	$0	($0.02)	($0.01)	($0.02)	($0.02)	$0
Previously Reported [Member]	'	'	'	'	'	'	'	'	'
Revenue	'	373	'	'	'	'	53,283	55,143	'
Cost of goods sold	'	1,392	'	'	'	'	35,499	36,411	'
Gross Profit	'	-1,019	'	'	'	'	17,784	18,732	'
Operating expenses	'	'	'	'	'	'	'	'	'
General, administrative and other	'	77,606	'	53,380	'	175,673	368,094	502,162	49,820
Marketing	'	10,847	'	43,131	'	183,129	970,379	982,637	5,863
Product development	'	'	'	21,744	'	37,019	37,019	37,077	45,413
Compensation	'	983,292	'	27,000	'	314,500	300,001	313,007	20,000
Total Operating Expenses	'	1,071,745	'	145,255	'	710,321	1,676,493	1,834,886	121,096
Interest expense and finance costs	'	'	'	'	'	-8,389	-23,601	'	'
Loss from continuing operations	'	-1,072,764	'	-145,255	'	-718,710	-1,785,231	-2,178,910	-121,096
Discontinued operations, net	'	'	'	'	'	'	'	'	-25
Other income (expense)	'	'	'	'	'	'	'	'	'
Change in fair value of derivative liability	'	210,482	'	'	'	'	-118,133	242,430	'
Interest Expense	'	209,268	'	'	'	'	'	120,329	'
Total Other Expenses	'	419,750	'	'	'	'	'	'	'
Net (loss)	'	-1,492,514	'	-145,255	'	-718,710	-1,785,231	-2,178,910	-121,121
Net loss per common share	'	$0	'	$0	'	$0	$0	($0.02)	$0
Adjustments [Member]	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	'
Cost of goods sold	'	'	'	'	'	'	'	'	'
Gross Profit	'	'	'	'	'	'	'	'	'
Operating expenses	'	'	'	'	'	'	'	'	'
General, administrative and other	'	4	'	'	'	'	'	-220	16,415
Marketing	'	-1	'	'	'	'	'	'	'
Product development	'	'	'	'	'	'	'	'	'
Compensation	'	'	'	'	'	'	50,777	50,997	'
Total Operating Expenses	'	3	'	'	'	'	50,777	50,777	16,415
Interest expense and finance costs	'	'	'	'	'	'	'	'	'
Loss from continuing operations	'	-3	'	'	'	'	-50,777	'	16,415
Discontinued operations, net	'	'	'	'	'	'	'	-50,777	'
Other income (expense)	'	'	'	'	'	'	'	'	'
Change in fair value of derivative liability	'	687,585	'	'	'	'	'	'	'
Interest Expense	'	'	'	'	'	'	'	'	'
Total Other Expenses	'	687,585	'	'	'	'	'	'	'
Net (loss)	'	($687,588)	'	'	'	'	($50,777)	($50,777)	$16,415
Net loss per common share	'	($0.02)	'	$0	'	$0	($0.02)	$0	$0